WuXi AppTec Revenue and Competitors
Estimated Revenue & Valuation
- WuXi AppTec's estimated annual revenue is currently $1.1B per year.
- WuXi AppTec's estimated revenue per employee is $201,000
Employee Data
- WuXi AppTec has 5231 Employees.
- WuXi AppTec grew their employee count by -5% last year.
WuXi AppTec's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, International Sales & Marketing | Reveal Email/Phone |
3 | Head US WIND Team/Director Program Management | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | VP and Head Immuno-Oncology at HDBiosciences Inc | Reveal Email/Phone |
6 | VP Operations & General Manager | Reveal Email/Phone |
7 | SVP, Research Service Division | Reveal Email/Phone |
8 | VP Operations | Reveal Email/Phone |
9 | Associate Study Director | Reveal Email/Phone |
10 | Director Key Accounts | Reveal Email/Phone |
WuXi AppTec Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $86.4M | 430 | 8% | N/A | N/A |
What Is WuXi AppTec?
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities such as small molecule R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, and medical device testing, WuXi platform is enabling more than 3,500 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi's dream that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
keywords:N/A
N/A
Total Funding
5231
Number of Employees
$1.1B
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
WuXi AppTec News
SINGAPORE, April 28, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, and A*STAR's...
The CDMO unit of Wuxi AppTec, WuXi ATU, is partnering with a Singapore research group to advance cell and gene therapy manufacturing in the Asia...
SHANGHAI, April 25, 2022 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of...
SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Morgan Stanley Capital International ("MSCI") has upgraded its MSCI ESG Rating to AA. The Company also received outstanding scores in the areas of "corporate governance" and "product safety and qualit ...
Other Companies in Mendota Heights
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6380M | 6016 | 8% | N/A |
#2 | $1699.8M | 6772 | N/A | N/A |
#3 | $26270M | 24875 | 5% | $20M |